Idiopathic pneumonia syndrome (IPS) is a common, often fatal, complication following hematopoietic stem cell transplantation (HSCT) characterized by severe pneumonitis and interstitial fibrosis. Fully reconstituted syngeneic bone marrow transplant (BMT) mice infected with murine c-herpesvirus-68 develop interleukin-17 (IL-17)-driven pneumonitis and fibrosis, which mimics clinical manifestations of IPS. We found CD103 þ and CD11b þ dendritic cells (DCs) are selectively deficient for the Notch ligand, DLL4, following BMT and CD4 þ T cells isolated from lungs and spleens of infected BMT mice display Notch signaling defects. Mice transplanted with CD4 À Cre-driven dominant-negative Notch transcriptional regulator Mastermind-Like (CD4-Cre-DNMAML (CCD) mice) bone marrow displayed elevated IL-17 and transforming growth factor-b (TGF b) in the lungs, a further expansion of T-helper type 17 (Th17) cells, and developed more fibrosis than wild-type (WT)-BMT mice. Culture of BMT lung leukocytes with recombinant Notch ligand, DLL4, restored Notch signaling and decreased production of IL-17. Adoptive transfer of CD11c þ DCs could restore Th1 and limit Th17 in WT-BMT but not CCD-BMT mice, indicating that a specific DC/CD4 þ T-cell Notch interaction modulates IL-17 production following reconstitution in syngeneic BMT mice. Given recent clinical observations showing that patients with pulmonary complications post-transplant harbor occult herpesvirus infections, these data provide mechanistic insight and suggest potential therapies for these devastating conditions.
INTRODUCTION
Hematopoietic stem cell transplantation (HSCT) is an efficacious curative therapy for a number of malignant and autoimmune diseases. 1, 2 Unfortunately, severe and often fatal lung complications such as idiopathic pneumonia syndrome (IPS) and bronchiolitis obliterans syndrome are common following HSCT affecting between 10 and 15% of recipients. 3, 4 Aberrant production of proinflammatory cytokines such as interleukin-6 (IL-6) and IL-17A are thought to play important roles in the progression of IPS and bronchiolitis obliterans syndrome; [5] [6] [7] however, the cellular mechanisms that underlie the production of these cytokines remain unclear.
The Notch pathway is an evolutionarily conserved juxtacrine intercellular signaling pathway important in a variety of biological processes such as cell division and differentiation, organ development, and lymphocyte maturation/activation. Four Notch receptors (Notch1-4) are expressed by mammalian cells and can be activated by contact with a second cell expressing one of five Notch ligands (DLL1, 3, and 4 and Jagged1 or -2). 8, 9 Interactions with these cognate ligands result in an initial cleavage of the Notch receptor in the plasma membrane by ADAM (A disintegrin and metalloproteinase) proteases. 10 The receptor subsequently undergoes endocytosis where it undergoes a second cleavage by the intramembrane protease g-secretase releasing an active Notch intracellular domain. The Notch intracellular domain transits to the nucleus where it acts as a scaffold for transcription machinery including p300 and master mind-like (MAML). 11 The formation of this transcription complex de-represses the transcriptional repressor CBP/RBPj-k turning on the expression of Notch-specific target genes such as the Hairy enhancer of split (Hes) family of proteins. 12 Engagement of Notch receptors on CD4 þ T cells by ligand expressing antigen-presenting cells (APCs) has been shown to influence T-cell polarization into the various activated subsets (e.g. Th1, Th2, Th17). This process is dependent on a variety of factors including antigen and cytokine exposure and can be either activating or inhibitory. The expression of the Notch ligands DLL4 or Jagged1 by APCs was shown to preferentially result in naïve T cells skewing towards either Th1 or Th2, respectively. 13 Exposure of naïve T cells to plate-bound or APCexpressed DLL4 was shown to drive Th17 differentiation when the cells were grown in the context of the Th17-skewing cytokines, IL-6 and transforming growth factor-b (TGF-b). 14 Further the IL-17 promoter was demonstrated to be a direct transcriptional target for the Notch intracellular domain complex. 14, 15 In contrast, several studies have shown that Notch ligand expression by APCs can attenuate T-cell cytokine expression. Expression of Jagged1 by APCs pulsed with the dust mite antigen Der P1 was found to expand populations of T-regulatory cells and induce a tolerogenic phenotype upon antigen re-exposure. 16 Pulsing of bone marrow-derived dendritic cells with BCG expressing recombinant Der P2 antigen increased expression of the Notch ligand DLL4 and adoptive transfer of these bone marrow-derived dendritic cells decreased Th17 differentiation and lessened allergic airway inflammation in an experimental mouse model of asthma. 17 DLL4 was also shown to be increased following respiratory syncytial virus infection. 18 Treatment of respiratory syncytial virus-infected mice with aDLL4 antibody therapy exacerbated airway inflammation and increased IL-17 responses. 18, 19 More recently, T cells cultured with Jagged1 were found to be significantly inhibited in their ability to produce IL-17 when cocultured with the Th17-skewing cytokines IL-6 and TGFb. 20, 21 Additionally, T cells isolated from patients with systemic lupus erythematosus were found to be deficient in Notch1 signaling and produced elevated levels of IL-17A. 22 Thus, the ultimate role of Notch signaling during T-cell activation is highly context dependent, highlighting the need to study this pathway in detail in specific disease states.
We have previously characterized a mouse model of pneumonitis and pulmonary fibrosis following g-herpesvirus-68 (gHV-68) infection in syngeneic bone marrowtransplanted (BMT) mice that strongly resembles clinical manifestations of IPS and the fibrotic properties of bronchiolitis obliterans syndrome in humans that have undergone HSCT. In normal, nontransplanted mice, gHV-68 clearance from the lungs happens within 10 days from the onset of intranasal infection via a strong polarization of CD4 þ T cells to a Th1 phenotype secreting large amounts of interferon-g (IFNg), which has been shown to limit the replication and spread of gHV-68. [23] [24] [25] BMT mice, however, show an increased polarization of CD4 þ T cells to a Th17 phenotype following gHV-68 challenge, secreting IL-17 instead of IFNg, resulting in a severe pneumonitis and pulmonary fibrosis, which is evident by 3 weeks postinfection. [26] [27] [28] Neutralization of IL-17 by administration of aIL-17 antibody therapy, or genetically ablating expression of IL-17 from donor hematopoietic cells completely abrogated disease. 27 It was further demonstrated that adoptive transfer of non-BMT CD11c þ APCs could reverse polarization of CD4 þ T cells back to a Th1 phenotype and alleviate the fibrosis in BMT mice infected with gHV-68, demonstrating a role for an APC-T-cell interaction in this altered immune response. 27 Given the important role of Notch signaling in T-cell activation, we asked whether Notch signaling was involved in regulating cytokine production from T cells following gHV-68 challenge after BMT. T cells isolated from the lungs and spleens of BMT mice had significant decreases in the expression of Notch-associated transcription factors following gHV-68 infection. Further, BMT mice transplanted with marrow specifically ablated for canonical Notch signaling only in CD4 and CD8 T cells exhibited increased the number of lunginfiltrating Th17 cells, higher levels of pathogenic IL-17 and TGF-b production, and developed more exuberant pulmonary fibrosis, indicating that T-cell Notch signaling is an important regulator of profibrotic cytokines following BMT and gHV infection.
RESULTS

Lung DCs display reduced expression of DLL4 in virally infected BMT mice
Notch ligand expression on CD11c þ APCs has been implicated in modulating T-cell activation and cytokine production during a variety of disease states and immunological maladies. [31] [32] [33] [34] [35] To determine whether levels of Notch ligands were altered on APCs following BMT and viral infection, total CD11c þ cells were isolated by magnetic bead separation from either control or BMT mouse groups and infected ex vivo at a multiplicity of infection of 1.0 for 24 h with gHV-68. Total RNA was isolated and expression levels of four Notch ligands (DLL1, DLL4, Jagged1, and Jagged2) were analyzed via quantitative real-time PCR (qRT-PCR). Expression of DLL4 was decreased in both uninfected BMT cells and in infected non-BMT cells in comparison with control non-BMT CD11c þ APCs, and an additive downregulation of DLL4 was noted in infected BMT APCs in comparison with control cells (B5-fold downregulation in comparison with control non-BMT cells; Figure 1a ). DLL1 was modestly, although not significantly, downregulated in uninfected BMT cells in comparison with wild-type (WT) control cells; however, no change was observed in cells isolated from infected mice ( Figure 1a ). Levels of Jagged2 were downregulated in infected BMT CD11c þ cells in comparison with WT control cells; however, no change in Jagged2 expression was noted in comparison with WT control cells ( Figure 1a ). No change in Jagged1 expression was observed in any of the groups (Figure 1a ). To analyze expression of Notch ligands on CD11c þ cells in vivo, we infected groups of control or BMT mice intranasally with gHV-68. After 7 days postinfection (dpi), flow cytometry was performed on collagenase-digested lung cells to assess APC expression of Notch ligands in vivo. Cells were first gated as CD45 þ , CD11c þ , and MHCII þ before gating on expression of either DLL1, DLL4, Jagged1, or Jagged2. In agreement with the ex vivo data, significantly fewer DLL4-positive CD11c þ cells were detected in the lungs of BMT mice at 7 dpi in comparison with non-BMT mice (Figure 1b and Supplementary Figure S1 online). The number of CD11c þ APCs expressing DLL1, Jagged1, or Jagged2 was not altered in gHV-68-infected BMT mice in vivo (Supplementary Figure S1) .
We further analyzed the expression of DLL4 on two distinct subsets of CD11c þ DCs, i.e., CD103 þ and CD11b þ DCs, by flow cytometry. In agreement with the decreased expression of DLL4 seen in the total CD11c þ DC compartment, the absolute number as well as the percentage of DLL4 þ CD103 þ DCs present in the lungs of BMT mice was significantly decreased at 3 dpi ( Figure 1c ). Percentage of CD11b þ DCs was similarly decreased in BMT mice at 3 dpi; however, there was not a statistically significant decrease in the absolute number ( Figure 1c) . Similarly, at 7 dpi both absolute number and percentage of CD103 þ DCs was decreased in BMT mice, and no change in either absolute number or percentage of CD11b þ DCs was observed at 7 dpi ( Figure 1d ). Representative flow plots (7 dpi) are shown for CD103 þ DCs in Figure 1e , and for CD11b þ DCs in Figure 1f , the full flow cytometry gating strategy is shown in Supplementary Figure S2 .
We next isolated CD4 þ T cells from the spleen as a source of naïve T cells from uninfected WT or BMT mice (0 dpi) or from the lungs of gHV-68-infected mice (7 dpi) and analyzed expression of the Notch target genes Hes1, Hes5, and Hey1, as well as the Notch1 and Notch2 receptors by qRT-PCR. Interestingly, in the absence of infection, expression of both Notch1 and Notch2, as well as all three Notch target genes, were decreased in T cells isolated from the spleens of BMT mice (Figure 2 ). At 7 dpi, the expression of Notch1 and Hes1 were significantly lower in T cells isolated from the lungs; however, the expression of Hes5 and Hey1 were not significantly different between BMT and WT mice and an increase in the expression of Notch2 was also noted ( Figure 2 ).
Abrogation of T-cell Notch signaling enhances Th17 differentiation and exacerbates cHV-68-induced pulmonary fibrosis following BMT
To assess whether T-cell-specific Notch signaling influenced Th17 differentiation during gHV-68 infection following syngeneic BMT, we used a genetic approach wherein C57BL/6J mice harboring a Cre recombinase under the control of the CD4 promoter were crossed with mice carrying a floxed dominant-negative version of the Notch transcriptional regulator MAML. 29 These CCD mice retain a normal repertoire of T cells but are functionally ablated for all canonical Notch signaling in both CD4 þ and CD8 þ T cells. Syngeneic BMTs were performed on lethally irradiated WT mice using either WT or CCD mice as donors. Following this, both transplanted and nontransplanted control groups were infected intranasally with gHV-68. Lungs were harvested at 7 dpi, collagenase digested, and analyzed by intracellular cytokine staining and flow cytometry for expression of either IFNg or (e and f) Leukocytes from collagenase-digested lungs were purified by centrifugation through Percoll. Cells were cultured overnight in complete media, without additional stimulation, and clarified supernatants were analyzed by enzyme-linked immunosorbent assay (ELISA). (g) CD4 þ T cells were magnetically purified from the spleens of either wild-type (WT), BMT, or CCD-BMT mice (n ¼ 3-4 mice per group), 1 Â 10 6 cells were cultured in the presence of the indicated skewing condition for 24 h, after which supernatants were harvested and analyzed for the indicated cytokine by ELISA (Unstim ¼ no additives, CD3 ¼ 1 mg ml À 1 aCD3 and aCD28, Th17 ¼ aCD3, aCD28, with 2 ng ml À 1 transforming growth factor-b and 20 ng ml À 1 IL-6). Statistical significance was calculated by analysis of variance (ANOVA). *Po0.05, **Po0.01, ***Po0.001, and ****Po0.0001. expressed by both CD4 þ and CD8 þ T cells during the double-positive stage of lymphocyte maturation, we also analyzed CD8 þ lymphocyte populations for the expression of both IL-17 and IFNg. In contrast to CD4 þ T cells, there was no difference in CD8 þ IFNg expression between gHV-68infected WT-BMT and CCD-BMT mouse groups (Figure 3a,d) . Additionally, IL-17 was only detected in a small population of CD8 þ T cells in BMT mice (o1%) and there was no difference between gHV-68-infected BMT and CCD-BMT mice (data not shown).
To further assess the levels of cytokines produced by control and BMT mice after gHV-68 challenge, cells from collagenasedigested lungs were purified by centrifugation through Percoll at 7 or 21 dpi, resulting in a 60-80% enrichment for CD45 þ hematopoietic cells as assayed by flow cytometry (Supplementary Figure S2 , panel 1). Cells were plated for 24 h in complete media (3 Â 10 6 per sample) and the amount of profibrotic cytokines IL-17 and TGF-b was measured by enzyme-linked immunosorbent assay (ELISA). In agreement with the greater number of Th17 cells recruited to the lungs of CCD-transplanted mice, cells isolated from the lungs of CCD-BMT mice produced more IL-17 and TGF-b than nontransplanted control or WT BMT mice at both 7 and 21 dpi (Figure 3e,f) . Additionally, CD4 þ T cells were isolated from the spleens of noninfected control, WT-BMT, or CCD-BMT mice and stimulated either with aCD3/aCD28 alone or with aCD3/aCD28 in conjunction with the Th17-skewing cytokines IL-6 and TGF-b. CD4 þ T cells isolated from CCD-BMT mice produced large quantities of IL-17 even in the absence of Th17-skewing cytokines and IL-17 production was further amplified in the presence of IL-6 and TGF-b ( Figure 3g ).
Loss of T-cell Notch signaling exacerbates cHV-68-induced pulmonary fibrosis following BMT
To address whether the increased levels of IL-17 produced by CCD mice in response to gHV-68 exacerbated the development of pulmonary fibrosis, hematoxylin and eosin, and Trichrome staining of formalin-fixed paraffin-embedded lung sections were examined microscopically for the presence of inflammation and fibrotic foci at 21 dpi. Masson's Trichrome staining highlights collagen-rich fibrotic areas with a blue color. Nontransplanted control mice infected with gHV-68 had no indication of inflammation or pulmonary fibrosis at 21 dpi (Figure 4a,b) , while infected BMT mice developed patchy fibrosis as evidenced by areas of interstitial thickening, inflammatory infiltrate, loss of alveolar structure, and deposition of excess collagen (Figure 4c,d) . CCD-BMT mice, however, developed a much more severe pneumonitis and fibrosis in response to gHV-68 with large areas of the lung showing loss of alveolar architecture, increased amounts of inflammatory infiltrate, and further increased collagen deposition (Figure 4e,f) . Interestingly, non-BMT CCD mice infected with gHV-68 for 21 days did not develop pulmonary fibrosis ( Supplementary Figure S3A,B) . Cytokine analysis from non-BMT WT or CCD mice revealed that although non-BMT CCD mice produced less IFNg at 7 dpi, levels of IL-17 were equivalent between the two groups ( Supplementary  Figure S3D ,E). Lung collagen content was directly quantified from either WT, BMT, or CCD-BMT mice at 21 dpi by hydroxyproline assay. In agreement with the increase in collagen noted by Masson's Trichrome staining, CCD-BMT mice had more collagen deposition than either WT or WT-BMT mice at 21 dpi (Figure 4g) . We further assayed lungs for amounts of infectious virus present at 7 dpi and noted a significant increase in viral load in the lungs of CCD-BMT mice in comparison with either WT or WT-BMT mice (Figure 4h) . To assess if CCD-BMT mice had a defect in viral clearance, we isolated total RNA from collagenase-digested lung cells at either 7 or 21 dpi and performed qRT-PCR for two viral transcripts (vDNA polymerase and glycoprotein B). Levels of both transcripts followed similar trends with transplanted mouse groups exhibiting increased expression at 7 dpi in comparison with non-BMT mice (Figure 4i,j) . At 21 dpi, expression of both viral transcripts was significantly lower in all groups, indicating that viral clearance was preserved in both BMT and CCD-BMT mice (Figure 4i ,j).
Adoptive transfer of WT CD11c þ cells into CCD-BMT mice fails to restore T-cell Notch signaling and does not rescue fibrotic lung pathology
We previously reported that adoptive transfer of WT CD11c þ cells into BMT mice could rescue fibrotic pathology by decreasing production of IL-17 from CD4 þ T cells. 27 To address the role of APC/T-cell Notch signaling in this system, we adoptively transferred magnetically sorted CD11c þ cells isolated from the lungs of gHV-68-infected WT mice into either WT-BMT or CCD-BMT mouse groups one day before infection with gHV-68 (1 Â 10 6 CD11c þ cells transferred intravenously). As reported previously, adoptive transfer of CD11c þ APCs completely rescued fibrotic pathology in WT-BMT mice (Figure 5a,b) . Interestingly, collagen-rich fibrotic nodes were still evident in the lungs of adoptively transferred T-cell Notch-deficient CCD-BMT mice at 21 dpi (Figure 5c,d) . We next assessed if the adoptive transfer of CD11c þ cells could restore the number of DLL4 þ cells to either the lungs or draining lymph nodes of BMT mice following gHV-68 infection. Interestingly, the number of DLL4 þ CD103 þ DCs were increased in the lungs by 7 dpi following adoptive transfer (Figure 5e) . In contrast, the number of CD11b þ DCs remain unchanged in the lungs and the number of both DLL4 þ CD103 þ and CD11b þ DCs remained low in the draining lymph nodes of both BMT and adoptively transferred BMT mice. To address directly the effects of CD11c þ cell transfer on T-cell Notch signaling, CD4 þ T cells were isolated from the lungs of either WT, BMT, or CCD-BMT mice at 7 dpi with or without CD11c þ APC adoptive transfer. Nontransferred WT-BMT CD4 þ cells expressed significantly lower amounts of the Notch target Hes1 in comparison with WT CD4 þ cells (Figure 5f ). Adoptive transfer of CD11c þ cells significantly increased Hes1 expression in WT-BMT CD4 þ cells, but failed to increase Hes1 expression in CCD-BMT CD4 þ cells (Figure 5f ). Lower numbers of Th17 cells were detected by flow cytometry in the lungs of WT-BMT mice that had received CD11c þ cellular adoptive transfer; however, CCD-BMT mice still had significantly elevated numbers of lung-infiltrating Th17 cells after transfer of CD11c þ cells (Figure 5g) . To address whether the adoptive transfer of CD11c þ cells had an ameliorative effect on the development of pulmonary fibrosis, we analyzed lung collagen content at 21 dpi by hydroxyproline assay. In agreement with the histological analysis, WT BMT mice that had received adoptive transfer of CD11c þ cells had significantly less collagen deposition than nontransferred BMT mice (Figure 5h) . In contrast, CCD-BMT mice that received CD11c þ cell transfer did not show a decrease in collagen deposition in comparison with nontransferred CCD-BMT mice and collagen levels in these mice remained significantly elevated in comparison with non-BMT mice (Figure 5h) .
In vitro culturing of lung leukocytes with recombinant DLL4 restores Notch signaling and decreases production of IL-17
We next attempted to restore Notch signaling by culturing purified lung leukocytes isolated from WT or BMT mice with plate-bound recombinant DLL4 (rDLL4). In agreement with in vivo observations, lung leukocytes cultured for 24 h in the absence of rDLL4 expressed lower levels of the Notch target gene Hes1 (Figure 6a ). Addition of rDLL4 increased the expression of Hes1 in BMT leukocytes, which correlated with a concomitant decrease in the expression of IL-17 transcript (Figure 6b) . We next quantified the amount of IL-17 produced from either WT or BMT leukocytes cultured in the presence or absence of rDLL4 by ELISA. In agreement with the level of IL-17 transcript measured by qRT-PCR, lung leukocytes from BMT mice cultured with rDLL4 secreted less IL-17 (Figure 6b,c) . As a control, leukocytes isolated from the lungs of T-cell Notch signaling-deficient CCD-BMT mice were resistant to the effects of rDLL4 and produced increased amounts of IL-17 in comparison with rDLL4-treated WT-BMT lung leukocytes (Figure 6c ).
DISCUSSION
The impact of Notch signaling during the process of T-cell activation is complex and can range from activating to inhibitory depending on a variety of factors including: which specific Notch receptors and ligands are engaged, the type of T cells and APCs involved (naïve vs. previously activated or memory T cells) and the costimulatory and cytokine environment experienced by the T cell during activation. 36, 37 Here we present evidence that the loss of CD4 þ T-cell Notch signaling during gHV-68 infection following BMT promotes the differentiation of Th17 cells and facilitates the development of IL-17-driven pneumonitis and pulmonary fibrosis that resembles features of human IPS and bronchiolitis obliterans syndrome post-transplant.
In contrast to some previously reported studies, which suggested that activation of the Notch signaling pathway in T cells preferentially enhanced IL-17 production, 14, 15 we found that CD4 þ T cells isolated from the lungs of BMT mice exhibited an increased capacity to produce IL-17; however, production of IL-17 correlated with a decrease in Hes1 and Notch1 expression, indicating a suppressive effect of Notch signaling on IL-17 production following BMT. These outcomes are likely due to loss of Notch1 as Notch2 expression does recover by 7 dpi. Furthermore, although not apparent in the normalized expression values shown in Figure 2 , Notch2 was expressed at a much lower level than Notch1 under basal conditions. Several previous studies have shown that the expression of Hes1 can suppress T-cell cytokine production and proliferation. Administration of activating a-Notch1 or a-Notch2 antibodies increased the expression of Hes1 and Figure 6 Ex vivo treatment of purified lung leukocytes with recombinant DLL4 restores Notch signaling and decreases interleukin-17 (IL-17) production. (a and b) Lung leukocytes were isolated from wild-type (WT) or bone marrow transplant (BMT) mice at 7 days postinfection (dpi) and cultured with or without 50 nM recombinant DLL4 for 24 h. Total RNA was analyzed by quantitative real-time PCR (qRT-PCR) for the indicated transcript. (c) Lung leukocytes were isolated from either WT, BMT, or CD4-Cre-DNMAML-BMT (CCD-BMT) mice at 7 dpi, incubated for 24 h with or without 50 nM DLL4. Supernatants were harvested and analyzed for IL-17 by enzyme-linked immunosorbent assay (ELISA). Statistical significance was calculated by analysis of variance (ANOVA). *Po0.05, **Po0.01, ***Po0.001, and ****Po0.0001 (n ¼ 4-5 mice per group)., decreased phosphorylation of AKT leading to decreased secretion of IL-2. 36, 38 Likewise, genetic ablation of Notch1 and Notch2, specifically in T cells, led to increased expression of RoRgT and Th17 differentiation. 39 Furthermore, a specific jagged1-Notch1 interaction was identified in T cells that suppressed production of IL-17 produced because of TGF-b and IL-6 stimulation. 20 Thus, it is plausible that the decreased expression of Notch1/Hes1 by CD4 þ T cells subsequently increased production of IL-17 following BMT.
Interestingly, DLL4 expression was downregulated on BMT CD11c þ APCs in the absence of infection (Figure 1a) . Likewise, Notch1 and Hes1 expression were decreased in naïve T cells isolated from the spleens of noninfected BMT mice (Figure 2, 0 dpi) , indicating that the processes of radio conditioning or immune reconstitution following conditioning may facilitate the generation of a pro-IL-17/Th17 environment. However, non-BMT CCD mice infected with gHV-68 do not develop IPS-like pneumonitis or fibrosis even though they have significantly higher viral loads at 7 dpi (Supplementary Figure  S3A -C). While IFNg levels were reduced in non-BMT CCD mice following gHV-68 infection, IL-17 levels were not elevated ( Supplementary Figure S3C,D) . Furthermore, uninfected BMT mice do not develop fibrotic pathology by 21 dpi. 26 Thus, it is likely that the conditioning regimen followed by an infectious stimulus is necessary to drive full elaboration of the Th17 response. In this regard, we have previously shown that lung epithelial cells are potent producers of TGFb post-BMT, further, CD11c þ cells isolated from gHV-68 infected BMT mice secrete pro-Th17 cytokines such as IL-6, IL-23, and TGFb, which could help promote robust Th17 responses. 27, 40 We observed decreased expression of the Notch ligand DLL4 on CD11c þ APCs following syngeneic BMT, but this result is in contrast to literature related to allo-transplantation and graft-versus-host disease (GVHD). DLL4 expression has most recently been attributed to a population of hyper-inflammatory plasmacytoid-like DCs that are associated with acute GVHD following allogeneic BMT. 31, 33, 34 These DLL4-hi inflammatory plasmacytoid-like DCs express CD11b and B220 and drive robust proliferation of alloreactive T cells that produce high levels of IFNg and IL-17. 34 Interestingly, blockade of DLL4 using a-DLL4 therapy, or genetic ablation of T-cell Notch signaling, was shown to lessen IFNg and IL-17 production during acute GVHD improving disease outcomes. 29, 34 However, adoptive transfer of alloreactive CD4 þ T cells that had been cultured specifically with, Flt3-matured, DLL4-hi DCs were unable to mediate experimental GVHD even though they produced high levels of both IFNg and IL-17. 31 Thus, the ultimate role of DLL4 governing GVHD remains unclear and is dependent on the model system.
Given the previous data supporting an activating role of T-cell Notch signaling on Th17 differentiation during allo-BMT, we were surprised to find that infiltration of DLL4-low CD11c þ APCs drives IL-17 responses and fibrosis during IPSlike pulmonary complications associated with viral infections following syngeneic BMT. One explanation for the apparent disparate functions of DLL4 in driving T-cell activation following BMT is that the subsets of DCs that are important for driving these immune reactions may be context-dependent, or may be completely different between models. The inflammatory plasmacytoid-like DCs observed during alloreactive GVHD are thought to be host-derived and spike in number very early (3 days) after transplant and reduce in number by 7 days post-BMT. 34 Our model uses fully immune-reconstituted BMT mice (5 weeks post-BMT at the time of infection) and presumably these inflammatory plasmacytoid-like DCs would be low in number in our model.
Further, DCs are highly heterogeneous with many specialized subsets. For instance, the lung contains populations of DCs that are either CD11b þ CD103 À or vice versa, while the major population in the intestinal lamina propria are CD11b þ CD103 þ DCs. [41] [42] [43] Both lung and intestinal CD11b þ DCs promote Th17 responses; however, CD103 þ CD11b À DCs are thought to promote exclusively Th1 responses. 41, 44, 45 Interestingly, we found that the expression of DLL4 was preferentially reduced on the CD103 þ CD11b À DC subset in the lungs of syngeneic BMT mice following gHV-68 infection. It is plausible that the lack of DLL4 on CD103 þ DCs is partially responsible for the decreases inTh1 differentiation and IFNg production observed in BMT mice in response to gHV-68, and that in the absence of a proper Th1 response, a Th17 response is generated instead.
We previously published that adoptive transfer of CD11c þ cells from non-BMT mice rescued fibrotic pathology. 27 We now show adoptive transfer of these DLL4-hi DCs preferentially increased the number of DLL4 þ CD103 þ DCs in the lungs following infection leading to a restoration of Hes1 expression in CD4 þ T cells and decreased Th17 differentiation. We further demonstrated that T-cell Notch-deficient CCD-BMT mice were resistant to this effect and maintained Th17 differentiation and low CD4 þ Hes1 expression following adoptive transfer of CD11c þ cells, suggesting a specific interaction between Notch receptor expressing CD4 þ T cells and DLL4 expressing CD103 þ DCs in the lung ( Figure 6) . These data support a crucial role for DC-T cell Notch signaling in regulating IL-17 levels post-BMT; however, we do acknowledge that adoptive transfer of DCs into the CCD BMT mice has some impact on lowering Th17 cells and increasing the number of Th1 cells (Figure 5f and data not shown). This could reflect effects on radio-resistant host T cells, which would have been Notch sensitive or may suggest that there are additional Notch-independent effects of adoptively transferred DCs to limit Th17, and promote Th1, induction. Additionally, baseline secretion of low levels of IL-17 was observed in non-BMT-infected mice (Figure 6c) . Several other lymphocyte cell types, e.g., gd T cells, ILC3s, and invariant NKT cells, are known to secrete IL-17 and could account for these Notch-independent secretion effects. However, given that the adoptive transfer of CD11c þ cells restored Notch signaling specifically in CD4 þ Tcells and this correlated with decreased number of lung Th17 cells, we conclude that Notch signaling specifically acts to suppress IL-17 responses from CD4 þ sources following BMT and viral infection.
While human IPS is defined as being noninfectious, recent studies using more sensitive PCR techniques have demonstrated that over 50% of IPS cases are characterized by a previously undetected HV infection, HHV6. [46] [47] [48] These clinical data suggest that IPS could be subsequent to an occult infectious insult. This is consistent with our data showing clearance of lytic virus by 10 dpi, but development of severe pneumonitis and fibrosis by 21 dpi in the syngeneic BMT mice. Additionally, in a study analyzing 738 HSCT patients at the University of Michigan, both HHV6 and EBV infections within the first 100 days following transplant were strongly correlated with the development of IPS, with associated hazard ratios of 5.9 and 10, respectively (X Zhou, unpublished observation). Thus, while IPS can certainly manifest because of alloimmunity following HSCT, 6 we strongly feel that infection with HVs is an additional stimulus to the development of pulmonary pathology following HSCT.
In summary, our results have demonstrated a selective loss of DLL4 that occurs on lung DCs at 5 weeks post-BMT, when immune reconstitution is complete. Furthermore, there is basal loss of Notch1 and Notch2 receptors on T cells post-BMT at this same time point. In the syngeneic BMT setting, this defect in Notch signaling promoted a robust Th17 response, which worsened pneumonitis and fibrosis. We have previously shown the ability of IL-17 to promote lung mesenchymal cell activation (both proliferation and extracellular matrix deposition). 27 This pathologic Th17 response in the syngeneic setting is largely restored by adoptive transfer of primed DCs from nontransplanted mice, suggesting that in the setting of autologous HSCT complicated by HV infection, that cellular adoptive therapy or strategies to activate Notch signaling on T cells may have merit. Given the realization that pulmonary sequela of HSCT are often complicated by occult HV infection, this may provide some insight into the etiology of these complications. Further work will be needed to identify strategies and time frames to promote anti-viral response while limiting GHVD in allogeneic transplants and fibrotic outcomes in both autologous and allogeneic transplant settings.
METHODS
Cell lines, virus strains, and mouse lines. Murine gHV-68 (strain WUMS VR-1465) was purchased from ATCC (Manassas, VA) and was propagated and titrated on NIH 3T12 fibroblast monolayers also purchased from ATCC. T-cell Notch-deficient mice (CCD mice) expressing a floxed dominant-negative copy of the Notch transcriptional activator MAML in combination with a Cre recombinase gene under the control of the CD4 promoter were first described in ref. 29 and were generously provided to us by Dr. Ivan Maillard (University of Michigan, Ann Arbor, MI). Mice were maintained by mating of homozygous (flox/flox) to each other and were genotyped for the presence of the floxed DNMAML and CD4 Cre genes before use. Control C57BL/6J mice were purchased from Jackson Laboratories (Bar Harbor, ME). All mice were used between 6 and 8 weeks of age and were housed in specific pathogen-free conditions. Experiments were approved by the University of Michigan Institutional Animal Committee on Use and Care. Syngeneic bone marrow transplantation has been previously described in ref. 26 In short, C57BL/6J mice were lethally irradiated with 13 Gy (two split doses of 6.5 Gy spaced 3 h apart) from a 137 Cs radiation source. Mice were subsequently intravenously injected with 5 Â 10 6 bone marrow cells isolated from either genetically identical C57BL/6J mice or congenic CCD mice. BMT mice were given acidified water (pH 3.3) for 3 weeks and then switched to plain water for an additional 2 weeks. After a 5-week reconstitution period, BMT or control mice were infected intranasally with 5 Â 10 4 PFU gHV-68.
Preparation of single-cell suspensions from lung tissue and flow cytometry. Collagenase digestion of mouse lung tissue was previously described in ref. 30 In short, mice were euthanized by CO 2 asphyxiation after which perfusion was carried out by injecting 3-5 ml of phosphatebuffered saline through the right ventricle of the heart. Lungs were resected, minced with scissors, and digested in complete Dulbecco's modified Eagle's medium containing 15 mg ml À 1 collagenase A (Roche, Indianapolis, IN), and 2,500 U of DNase I (Sigma-Aldrich, St Louis, MO) for 30 min at 37 1C. Digested tissue was disrupted through a 10 ml syringe, filtered through a 100 mM pore size nytex screen, and centrifuged through a 20% Percoll solution in serum-free media. A total of 10 Â 10 6 cells were then stained with appropriately diluted fluorophore-conjugated antibodies for 30 min. For intracellular cytokine staining cells were diluted to 1 Â 10 6 /ml and stimulated for 4 h with phorbol 12-myristate 13-acetate (10 ng ml À 1 ), ionomycin (10 mM), and Golgi-stop reagent (BD Bioscience, San Jose, CA). Antibodies used in this study are as follows: anti-CD45, CD11b, CD4, IL-17A, MHCII (I-A b ), CD103, SiglecF (BD Bioscience), CD11c, IFNg (eBioscience, San Diego, CA), DLL1, DLL4, Jagged1, Jagged2, and CD64 (BioLegend, San Diego, CA).
Preparation of RNA and quantitative real-time PCR. Total RNA was extracted from either whole lung tissue or purified cells with TRIzol reagent (ThermoFisher, Waltham, MA) following the manufacturer's directions. One hundred nanogram of RNA per sample was analyzed using Taqman RNA to CT Real-Time Master Mix (ThermoFisher) on an ABI StepOnePlus Thermocycler (ThermoFisher). Primers used in this study are detailed in Table 1 .
Preparation of lung tissue sections for histology. Formalin-fixed paraffin-embedded lung sections were prepared as follows. Mice were euthanized by CO 2 asphyxiation, after which 3-5 ml of phosphatebuffered saline was perfused through the right ventricle of the heart. Lungs were infused with 1 ml 10% formalin solution through the trachea and fixed for 24 h, after which lungs were dehydrated in 70% ethanol, embedded in paraffin and sectioned to a 10 mM thickness. Lung sections were subsequently stained with hematoxylin and eosin or Masson's Trichrome stain to highlight collagen fibers.
Quantitation of collagen by hydroxyproline assay. Collagen content was assessed in whole lung homogenates using the hydroxyproline assay as described in ref. 30 Cytokine quantitation. Percoll-purified lung leukocytes from collagenase-digested lung tissue or magnetically isolated CD4 þ T cells (3 Â 10 6 per sample) were cultured for 24 h with or without additional skewing cytokines. Clarified supernatants were subsequently analyzed for the indicated cytokines using DuoSet ELISA Assays (R&D Systems, Minneapolis, MN). Recombinant murine DLL4 (R&D Systems) was plate bound to tissue culture dishes at a concentration of 50 nM in phosphate-buffered saline for 3 h at 37 1 C. Plates were washed 3 Â with sterile phosphate-buffered saline before addition of purified leukocytes in complete media. SUPPLEMENTARY MATERIAL is linked to the online version of the paper at http://www.nature.com/mi
